Back to Search
MARY CANDELARIA, RPH,MBA,PHARMD
RPH,MBA,PHARMD
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
NPI: 1023283991Individual
Specialties, Licenses & Credentials
Pharmacist Clinician (PhC)/ Clinical Pharmacy SpecialistPrimary
Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Code: 1835P0018X
RP00005474(NM)
Research & Publications (20)
Weekly topotecan as second- or third-line treatment in patients with recurrent or metastatic cervical cancer.
PMID 19016011·Med Oncol·2009
3-trial
Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients.
PMID 19220882·World J Surg Oncol·2009
4-observational
Thiopurine S-methyltransferase gene (TMPT) polymorphisms in a Mexican population of healthy individuals and leukemic patients.
PMID 18188716·Med Oncol·2008
8-other
The prince and the pauper. A tale of anticancer targeted agents.
PMID 18947424·Mol Cancer·2008
6-review
Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors.
PMID 18226465·Cancer Treat Rev·2008
6-review
Concurrent chemoradiation with carboplatin for elderly, diabetic and hypertensive patients with locally advanced cervical cancer.
PMID 19115688·Eur J Gynaecol Oncol·2008
3-trial
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.
PMID 17761710·Ann Oncol·2007
3-trial
Tamoxifen-associated vasculitis in a breast cancer patient.
PMID 17244373·World J Surg Oncol·2007
5-case
Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma.
PMID 16457727·Int Semin Surg Oncol·2006
8-other
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines.
PMID 16448574·Cancer Cell Int·2006
8-other
Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results.
PMID 16464243·BMC Womens Health·2006
8-other
A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.
PMID 17183730·PLoS One·2006
3-trial
Radiation-sparing managements for cervical cancer: a developing countries perspective.
PMID 17101048·World J Surg Oncol·2006
8-other
Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer.
PMID 17014709·Cancer Cell Int·2006
8-other
Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer.
PMID 16720917·Med Oncol·2006
8-other
Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer.
PMID 16483720·Cancer Treat Rev·2006
6-review
[Gestational trophoblastic disease. Experience at National Institute of Cancerology].
PMID 16309037·Ginecol Obstet Mex·2005
8-other
Epigenetics of cervical cancer. An overview and therapeutic perspectives.
PMID 16248899·Mol Cancer·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2100 CARLISLE BLVD NE, KMART PHARMACY
ALBUQUERQUE, NM 87110 - Phone
- (505) 265-3549
Quick Facts
- NPI
- 1023283991
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile